Coinjection of amyloid β peptide(25-35) and ibotenic acid does not create an animal model for Alzheimer's disease.

被引：0
|
作者：
Laksafoss, T [1 ]
Jorgensen, OS [1 ]
机构：
[1] Rigshosp 6102, Lab Neuropsychiat, DK-2100 Copenhagen, Denmark
来源：
EUROPEAN JOURNAL OF NEUROSCIENCE | 1998年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
3232
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [31] Interaction between Alzheimer's Aβ(25-35) peptide and phospholipid bilayers: The role of cholesterol
    D'Errico, Gerardino
    Vitiello, Giuseppe
    Ortona, Ornella
    Tedeschi, Annamaria
    Ramunno, Anna
    D'Ursi, Anna Maria
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2008, 1778 (12): : 2710 - 2716
  • [32] Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
    Wei, Mengying
    Liu, Yuanyuan
    Pi, Zifeng
    Yue, Kexin
    Li, Shizhe
    Hu, Mingxin
    Liu, Zhiqiang
    Song, Fengrui
    Liu, Zhongying
    RSC ADVANCES, 2019, 9 (32) : 18308 - 18319
  • [33] Role of amyloid beta (25-35) neurotoxicity in the ferroptosis and necroptosis as modalities of regulated cell death in Alzheimer's disease
    Naderi, Soudabeh
    Khodagholi, Fariba
    Pourbadie, Hamid Gholami
    Naderi, Nima
    Rafiei, Shahrbanoo
    Janahmadi, Mahyar
    Sayehmiri, Fatemeh
    Motamedi, Fereshteh
    NEUROTOXICOLOGY, 2023, 94 : 71 - 86
  • [34] Amyloid β-Peptide 25-35 Self-Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment
    Naldi, Marina
    Fiori, Jessica
    Pistolozzi, Marco
    Drake, Alex F.
    Bertucci, Carlo
    Wu, Rongliang
    Mlynarczyk, Krzysztof
    Filipek, Slawomir
    De Simone, Angela
    Andrisano, Vincenza
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (11): : 952 - 962
  • [35] Human platelet calcium mobilisation in response to β-amyloid (25-35):: buffer dependency and unchanged response in Alzheimer's disease
    Hedin, HLM
    Eriksson, S
    Fowler, CJ
    NEUROCHEMISTRY INTERNATIONAL, 2001, 38 (02) : 145 - 151
  • [36] Pelargonidin improves memory deficit in amyloid β25-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress
    Sohanaki, Hamid
    Baluchnejadmojarad, Tourandokht
    Nikbakht, Farnaz
    Roghani, Mehrdad
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 85 - 91
  • [37] Nitric oxide (NO) and amyloid beta protein in an animal model of Alzheimer disease.
    Ali, AK
    Banks, WA
    Farr, SA
    Kumar, VB
    Morley, JE
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S55 - S55
  • [38] Alzheimer's type amnesia, neurodegeneration and oxidative stress in the brain induced by ICV administration.: Of β-amyloid peptide (25-35) to rats
    Stepanichev, M
    Victorov, I
    Onufriev, M
    Mitrokhina, O
    Moiseeva, Y
    Lazareva, N
    Gulyaeva, N
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 94 - 94
  • [39] Amyloid-induced aggregation and precipitation of soluble proteins:: A electrostatic contribution of the Alzheimer's β(25-35) amyloid fibril
    Konno, T
    BIOCHEMISTRY, 2001, 40 (07) : 2148 - 2154
  • [40] Mesenchymal stem cells after the proprocessing of tanshinone IIA attenuate cognitive deficits and oxidative stress injury in an amyloid β-peptide (25-35)-induced rodent model of Alzheimer's disease
    Ba, Zhisheng
    Shi, Shangpeng
    Huang, Nanqu
    Li, Yuanyuan
    Huang, Juan
    You, Chao
    Yang, Xiaoyan
    Liu, Daishun
    Yu, Changyin
    He, Yuqi
    Luo, Yong
    NEUROREPORT, 2022, 33 (02) : 61 - 71
12345